Stephen D. Ryder

Has grant

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Does knowledge of liver fibrosis affect high risk drinking behaviour (KLIFAD)? A feasibility randomised controlled trial.

Open Date: 2020-09-01

Close Date: 2022-08-31

Grant: Close

NIHR Nottingham University Hospitals Clinical Research Facility

Open Date: 2017-04-01

Close Date: 2022-03-31

Grant: Close

Albumin to prevent infection in Acute-on-Chronic Liver Failure (ATTIRE)

Open Date: 2014-10-01

Close Date: 2019-08-31

Grant: Close

Albumin to prevent infection in Acute-on-Chronic Liver Failure (ATTIRE)

Open Date: 2014-10-01

Close Date: 2019-08-31

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

View details

William Rosenberg

University College London

UNITED KINGDOM

View details

helen jarvis

GP Clinical Lecturer

Newcastle University

UNITED KINGDOM

View details

Julie McDonald

Lecturer

Imperial College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephen D. Ryder

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance

Alcohol‐related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study

Engagement with community liver disease management across the UK: a cross-sectional survey

Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries

Collaborators (8)

Joanne Morling

Jessica Katharine Dyson

John Dillon

Kushala Abeysekera

Gideon M. Hirschfield

William Rosenberg

helen jarvis

Julie McDonald

Make your next move.